Information & advocacy — not medical advice. We don't sell the drug; we help you afford it. Figures current as of June 2026.
← All drugs Foundayo weight loss (obesity)
orforglipron · made by Eli Lilly · oral pill (daily)
Verified June 2026
Approved for weight loss (obesity)
List price self-pay from $149/mo
Cheapest legitimate cash path Self-pay from $149/mo (lowest dose); as little as $25/mo with a commercial-insurance savings card; ~$50/mo for eligible Medicare Part D via the GLP-1 Bridge. Source: Eli Lilly — Foundayo (orforglipron) oral GLP-1 pill approved & available ↗
Good to know FDA-approved Apr 1 2026 — the first GLP-1 PILL for weight loss, taken any time of day with no food/water restrictions (~27 lb average at the highest dose). Boxed warning: thyroid C-cell tumors (MTC); not for anyone with a personal/family history of MTC or MEN 2.
How to pay less
Before you act: This is information, not medical or insurance advice. GLP-1s carry real risks (some have a boxed thyroid-tumor warning). Prices and coverage change — confirm with your clinician, pharmacist, plan, or the official program before relying on anything here.
GLP1Compass We don't sell the drug. We help you pay for it. GLP1Compass maps every legitimate path to an affordable GLP-1 — insurance, the new Medicare Bridge, manufacturer cash prices, and how to appeal a denial — kept current as the 2026 rules keep changing.
Information only — not medical, legal, or insurance advice. GLP1Compass is not a pharmacy, prescriber, or insurer. Prices and coverage rules change; always confirm with the official source before acting.
Independent resource. Not affiliated with, endorsed by, or connected to Medicare, CMS, or any drug manufacturer. Information is general, may be out of date, and is not medical advice. Verify your eligibility and coverage with your insurer, pharmacist, or doctor before making decisions.
More tools from the same maker: Medicaid work requirement checker · iHateMeso — mesothelioma info without the lead gen
We use privacy-friendly analytics to improve this free resource. No ads tracking unless you allow it.
Allow Decline